6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline


Chemical Name: 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline
CAS Number: 922718-55-6
Product Number: AG00GULJ(AGN-PC-00TORP)
Synonyms:
MDL No:
Molecular Formula: C15H22BNO2
Molecular Weight: 259.1517

Identification/Properties


Computed Properties
Molecular Weight:
259.156g/mol
Hydrogen Bond Donor Count:
1
Hydrogen Bond Acceptor Count:
3
Rotatable Bond Count:
1
Exact Mass:
259.174g/mol
Monoisotopic Mass:
259.174g/mol
Topological Polar Surface Area:
30.5A^2
Heavy Atom Count:
19
Formal Charge:
0
Complexity:
329
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
N/A
Signal Word:
UN#:
-
Hazard Statements:
-
Precautionary Statements:
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline is a versatile compound commonly utilized in chemical synthesis for its unique properties and reactivity. This compound serves as a valuable building block in organic chemistry due to its ability to undergo various functionalization reactions, enabling the synthesis of diverse molecular structures. The boron-containing moiety in the molecule can act as a directing group for selective transformations, facilitating the formation of complex organic compounds with high regioselectivity and efficiency. Moreover, the tetrahydroisoquinoline scaffold offers a rigid and chiral framework, making it an ideal precursor for the synthesis of biologically active molecules and pharmaceutical intermediates. This compound finds applications in the synthesis of natural products, drug discovery, and materials science, showcasing its significance in advancing chemical research and development.